{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages mention \"Lockdown\" and \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe the context is from a study or report discussing lockdowns during a pandemic, like COVID-19.\n\nFirst, I need to define a lockdown. A lockdown is a public health measure where people are required to stay at home, and movement is restricted to prevent the spread of a disease. The context mentions the impact of non-lockdown, so maybe the study compares areas with and without lockdowns. The date 24/3/2020 is March 24, 2020, which is when many countries implemented lockdowns due to the pandemic.\n\nThe user might be looking for a clear, concise definition. Since the context is about estimating infections, the answer should connect lockdowns to controlling infection rates. I should mention that lockdowns aim to reduce transmission by limiting social interactions. Also, the context's focus on non-lockdown impact suggests that lockdowns are contrasted with other measures. Need to ensure the answer is accurate and ties into the provided context without adding external information.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and social interactions within a specific area or population, typically during a pandemic or public health crisis. Its primary goal is to reduce the spread of infectious diseases by minimizing contact between individuals, thereby slowing transmission rates. Lockdowns often involve mandatory stay-at-home orders, closure of non-essential businesses, and limitations on travel. The context provided references the impact of lockdowns on estimating infections, highlighting their role in mitigating outbreaks compared to scenarios without such restrictions.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look back at the provided context to find the relevant information.\n\nFirst, the passage mentions that most adults with severe CHIKF (Chikungunya Fever) have underlying medical conditions. Then it lists the complications from most common to least common. The order is respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. \n\nAdditionally, there's a part about neonates transmitting the virus during the perinatal period, leading to symptoms by day 4 of life. Six neonates developed meningoencephalitis. Wait, the original list already includes meningoencephalitis as a complication, so that's covered. The answer should include all these complications as listed, in order, and maybe mention the neonatal transmission part if it's a complication. But the question is about complications associated with CHIKV, so the main list is the key here. Let me make sure I didn't miss any. The answer should list them in the order given, from most common to least. Also, check if there are any other complications mentioned. The passage also mentions \"other central nervous system problems,\" so that's separate from meningoencephalitis. Alright, compiling all that into a clear answer.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus), listed from most common to least common, include:  \n1. **Respiratory failure**  \n2. **Cardiovascular decompensation**  \n3. **Meningoencephalitis**  \n4. **Severe acute hepatitis**  \n5. **Severe cutaneous effects**  \n6. **Other central nervous system problems**  \n7. **Kidney failure**  \n\nAdditionally, perinatal transmission of CHIKV can lead to severe morbidity in neonates, with symptoms appearing by day 4 of life and complications such as **meningoencephalitis** in confirmed cases. Underlying medical conditions in adults also contribute to severe outcomes.",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about \"Clade A,\" but looking through the passages, I notice mentions of clades like 1A.1, 1A.1.1, 1B.1, 1B.2, 1C, etc. The titles and passages discuss different lineages and their subdivisions.\n\nFirst, in the first passage, there's mention of within-clade exceptions for 1A.1 and 1A.1.1. Then, another passage talks about the 1A lineage containing 1,889 viruses from 34 countries, split into three second-order divisions. So 1A is a first-order clade that's divided further. However, the question is about Clade A, not 1A. Wait, maybe there's a typo or confusion here? The user wrote \"Clade A,\" but the context refers to clades like 1A, 1B, 1C, etc. \n\nLooking at the titles and passages again, there's no mention of a standalone \"Clade A.\" The clades are numbered with a number and a letter, like 1A, 1B, etc. The 1A lineage is discussed, which includes 1A.1 and 1A.1.1 as subdivisions. The answer might be that Clade A isn't explicitly mentioned, but if the user meant 1A, then 1A contains viruses from 34 countries collected from 2010 to the present, divided into three second-order clades. However, the question specifically says \"Clade A,\" which isn't directly addressed in the provided texts. Maybe the user made a mistake in the clade name? Alternatively, perhaps \"Clade A\" refers to the entire 1A lineage. Since there's no direct mention of Clade A, but there's 1A, I should check if there's any other reference. \n\nAnother passage mentions the 1C lineage, which is separate. The 1B lineage has exceptions like 1B.1 and 1B.2. The answer might be that the information isn't provided because \"Clade A\" isn't discussed, but if assuming 1A, then it's the lineage with 1,889 viruses from 34 countries",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 .",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 ."
      ],
      "computed_relevance": 0.15384615384615385,
      "computed_utilization": 0.7692307692307693,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the context provided. The context mentions that the S2 subunit is highly conserved with 99% identity among 2019-nCoV, bat SARS-like CoVs, and human SARS-CoV. But the question is about the S1 subunit.\n\nLooking further, the passage states: \"Though the S1 subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV, the core domain of RBD are highly conserved.\" So the key points here are that the S1 subunit has about 70% identity compared to the others, but the RBD core is conserved. \n\nAlso, there's a mention that unlike 2019-nCoV and human SARS-CoV, most bat SARSr-CoVs have two deletions in the spike receptor binding domain. This suggests that the S1 subunit's RBD in 2019-nCoV is more similar to human SARS-CoV than to bat versions, which have deletions.\n\nSo putting it together: The S1 subunit of 2019-nCoV shares about 70% identity with bat SARS-like CoVs and human SARS-CoV. However, the receptor-binding domain (RBD) core is highly conserved. In contrast, bat SARS-related CoVs have deletions in this RBD area, making their S1 subunits different from both 2019-nCoV and human SARS-CoV. Therefore, the S1 subunit of 2019-nCoV is more similar to human SARS-CoV in the RBD compared to bat versions, even though overall identity is 70%.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **approximately 70% identity** with the S1 subunits of bat SARS-like CoVs and human SARS-CoV. However, the **receptor-binding domain (RBD) core** within the S1 subunit is **highly conserved** across these",
      "retrieved_chunks": [
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context. First, I need to parse through the given information to find relevant details.\n\nLooking at the context, there's mention of Bacillus spp. subtilis restoring gut microflora by increasing beneficial species like Bifidobacterium, Lactobacillus, and Butyricicoccus, while reducing harmful ones like Acinetobacter, Ruminococcus, Clostridium, and Veillonella. That suggests B. subtilis has a probiotic effect on the gut.\n\nThe titles and passages talk about the secretome of intestinal bacilli as a natural guard against pathologies. They mention that Bacillus species, unlike Lactobacillus, weren't traditionally considered part of the normal intestinal microbiome but are found in feces. Also, Bacillus species are used in probiotics like Enterogermina, Biosubtyl, etc. The passage also notes that Lactobacillus and Bacillus are in traditional fermented foods and used in commercial probiotics.\n\nSo putting this together, Bacillus subtilis is a species of Bacillus that's used as a probiotic. It helps maintain gut health by balancing the microbiota. It's part of the Bacillus genus, which forms spores and can survive harsh conditions. The context also implies it's used in various probiotic products and has beneficial effects similar to Lactobacillus, even though it wasn't originally thought to be part of the normal gut flora.\n\nI need to make sure I don't miss any key points. The answer should mention that it's a probiotic bacterium, part of the Bacillus genus, used in fermented foods and commercial probiotics, and its role in restoring gut flora by increasing beneficial bacteria and reducing harmful ones. Also, note that it's spore-forming, which might help in its survival and effectiveness.\n</think>\n\nBacillus subtilis is a spore-forming, gram-positive bacterium belonging to the *Bacillus* genus. It is recognized as a probiotic species that supports intestinal health by restoring balance in gut microflora. Specifically, *B. subtilis* promotes the growth of beneficial gut bacteria (e.g., *Bifidobacterium*, *Lactobacillus*, *Butyricicoccus*) while reducing harmful species",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "Sporulation of B."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context about the 1889 pandemic. It mentions three major waves from 1889 to 1892, with the 1892 wave being the most intense. But the question is about single-wave pandemics. So maybe this isn't directly relevant, but it's talking about multiple waves. However, the context also mentions the 1918 pandemic's herald waves possibly stretching back to 1915. But again, the 1918 pandemic is known for having multiple waves. So maybe not directly answering the question, but providing some background on pandemic waves.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It talks about convalescent plasma treatment and studies on the origin and pathogenesis of the virus. The 2009 pandemic had multiple waves as well, though. The study here is about their response and research, but not specifically about single-wave pandemics.\n\nThird context is an economic analysis of mitigation strategies for five pandemic severity categories. It mentions studies using simulation models. The passage says they considered five gradations of pandemic severity and various interventions. However, the question is about research on single-wave pandemics. The mention of \"five gradations of pandemic severity\" might include different wave scenarios, but it's not clear if they specifically looked at single-wave cases. The context also references the 2009 pandemic data for health outcomes. Not sure if this is about single-wave.\n\nFourth context is about influenza virus circulation in Taiwan from 2008-2014, focusing on the 2009 pH1N1 pandemic. It discusses using a Richards model variation for multi-wave epidemics, distinguishing between turning points in waves. Since it's about multi-wave, this might not be relevant. However, the study extends previous research by considering different pandemic severities and interventions. The mention of \"multi-wave epidemic\" here contrasts with the question's focus on single-wave.\n\nLooking back at the question: What past research has been done on severe, single-wave pandemics?\n\nThe contexts provided don't explicitly mention single-wave pandemics. The 1889 pandemic had three waves, 1",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review."
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the context provided. The user is asking for the number of reported viral pneumonia cases, so I need to look through each of the provided passages to see if they mention any numbers related to viral pneumonia.\n\nFirst, looking at the first passage titled \"Clinical review: Primary influenza viral pneumonia,\" it mentions bacterial co-infection in the 2009 H1N1 pandemic. It says that 29% of 77 fatal cases had concurrent bacterial pneumonia. But this is about bacterial co-infection, not the number of viral pneumonia cases. So maybe not directly relevant here.\n\nNext, the second passage is about pneumonia in adults with seasonal influenza in the US from 2005\u20132008. It states that patients with pneumonia were more likely to receive antiviral therapy. Again, this is about treatment differences, not the count of cases.\n\nThird passage is the rapid advice guideline for 2019-nCoV. It mentions that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. This seems like a direct mention of viral pneumonia cases caused by the coronavirus. The number here is 2744. Also, there's a mention of 51 cured and discharged, 5794 suspected cases, etc. But the confirmed cases are 2744. Since the question is about reported viral pneumonia, this might be the key number.\n\nThe fourth passage again talks about influenza attack rates, giving examples from the 2009 H1N1 pandemic. It mentions percentages but not specific numbers of cases. So probably not the answer here.\n\nThe user's question is asking for the total number of reported viral pneumonia. The only passage that gives a specific number is the third one about 2019-nCoV, which states 2744 confirmed cases. The other passages discuss influenza-related pneumonia but don't provide specific counts except for the 77 fatal cases, which are about H1N1 in 2009. However, the question is about viral pneumonia in general. But since the user provided a context that includes different viruses (influenza and 2019-nCoV), but the only specific number given is 274",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The passage also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak. \n\nI should check the other passages to make sure there's no conflicting information. The second passage talks about genetic recombination and subgenomic sequencing, but it doesn't contradict the first point. The third passage discusses genome analyses focusing on specific regions like the spike protein, but again, the main method mentioned is still deep sequencing. The fourth passage mentions genomic techniques but doesn't provide an alternative method as the primary one. \n\nSo the answer should be high throughput or deep sequencing methods. The key term here is \"deep sequencing\" as mentioned in the first passage. The user might be looking for the specific technique, so I need to present that clearly.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach has been central to studying MERS-CoV's genetic variation, travel patterns, and recombination events, as highlighted in the context.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "The technique can produce genomic .",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the relevant methods mentioned.\n\nFirst, looking at the first context: They mention using an inverted fluorescence microscope to monitor plates until GFP expression was seen. That's one method, fluorescence microscopy.\n\nSecond context: They talk about using IVIS (In Vivo Imaging System) for whole-organ imaging of mouse lungs ex vivo. Also, flow cytometry was used to analyze infection progression in antigen-presenting cells. So IVIS and flow cytometry here.\n\nThird context: Expression of GFP was monitored during passaging by immunofluorescence microscopy using a GFP antibody. So immunofluorescence microscopy is another method mentioned here.\n\nFourth context: They mention using multi-photon intravital microscopy for in vivo visualization, with fluorescent proteins driven by certain promoters. So multi-photon intravital microscopy is another technique.\n\nPutting it all together, the answer should list the different imaging techniques used across the studies. The key points are fluorescence microscopy (inverted and immunofluorescence), IVIS for whole-organ imaging, flow cytometry, and multi-photon intravital microscopy. Each context contributes a different method, so the answer should compile all these methods as the ways the spread was tracked.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using multiple imaging techniques:  \n1. **Fluorescence microscopy** (inverted fluorescence microscope for monitoring GFP expression in cell cultures).  \n2. **IVIS (In Vivo Imaging System)** for whole-organ imaging of infected mouse lungs ex vivo.  \n3. **Flow cytometry** to analyze infection progression in antigen-presenting cells.  \n4. **Immunofluorescence microscopy** with a GFP antibody during passaging.  \n5. **Multi-photon intravital microscopy** for in vivo visualization of cytoplasmic fluorescent proteins.  \n\nThese methods collectively enabled tracking of viral spread across different experimental models and stages.",
      "retrieved_chunks": [
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since it's after a suspected case, maybe it's a typo or mistranslation. Possibly, they mean standard disinfection procedures even if the CT is noncontaminated? Or maybe it's a specific protocol for CT machines.\n\nThe answer should probably include steps like using appropriate disinfectants, following sterilization protocols, and doing it right after the exam. The context doesn't give detailed steps, but the main idea is immediate disinfection after the examination. So the answer would be that the recommended procedure is to disinfect the CT scanner immediately after the examination using the specified sterilization procedures.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. This includes preparing the necessary equipment and applying appropriate disinfection measures promptly to ensure safety and prevent potential contamination. The context emphasizes the importance of timely action post-examination to mitigate risks associated with suspected COVID-19 cases.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}